Selected research
Market Structure
Global Polymers Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Polymers Drug Delivery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Polymers Drug Delivery include Eisai, Sanofi, Johnson & Johnson, Vectura Group Plc, Tolmar, SurModics, Quark Pharmaceuticals Inc, Perrigo and Nektar Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Polymers Drug Delivery market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Polymers Drug Delivery and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Polymers Drug Delivery revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Polymers Drug Delivery market size, projected growth trends, production technologies, key applications, and end-use industries.
Polymers Drug Delivery Segment by Company
Eisai
Sanofi
Johnson & Johnson
Vectura Group Plc
Tolmar
SurModics
Quark Pharmaceuticals Inc
Perrigo
Nektar Therapeutics
Janssen Biotech
Inovio Pharmaceuticals
Heron
Gilead Sciences
Enzon Pharmaceuticals
EnColl Corporation
Allergan
Alkermes
Polymers Drug Delivery Segment by Type
Micelles
Dendrimer
Hydrogels
Microgels
Other
Polymers Drug Delivery Segment by Application
Medical Research Center
Pharmaceutical Factory
Other
Polymers Drug Delivery Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymers Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymers Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymers Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Polymers Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polymers Drug Delivery industry.
Chapter 3: Detailed analysis of Polymers Drug Delivery companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polymers Drug Deliveryrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Micelles
- Dendrimer
- Hydrogels
- Microgels
- Other
Applications
- Medical Research Center
- Pharmaceutical Factory
- Other
Companies covered
- Eisai
- Sanofi
- Johnson & Johnson
- Vectura Group Plc
- Tolmar
- SurModics
- Quark Pharmaceuticals Inc
- Perrigo
- Nektar Therapeutics
- Janssen Biotech
- Inovio Pharmaceuticals
- Heron
- Gilead Sciences
- Enzon Pharmaceuticals
- EnColl Corporation
- Allergan
- Alkermes
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Polymers Drug Delivery Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Micelles
- 1.2.3 Dendrimer
- 1.2.4 Hydrogels
- 1.2.5 Microgels
- 1.2.6 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Polymers Drug Delivery Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Medical Research Center
- 1.3.3 Pharmaceutical Factory
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Polymers Drug Delivery Growth Trends by Region
- 1.5.1 Global Polymers Drug Delivery Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Polymers Drug Delivery Market Size by Region (2021-2026)
- 1.5.3 Polymers Drug Delivery Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Polymers Drug Delivery Market Dynamics
- 2.1 Polymers Drug Delivery Industry Trends
- 2.2 Polymers Drug Delivery Industry Drivers
- 2.3 Polymers Drug Delivery Industry Opportunities and Challenges
- 2.4 Polymers Drug Delivery Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Polymers Drug Delivery Revenue by Company (2021-2026)
- 3.2 Global Polymers Drug Delivery Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Polymers Drug Delivery Key Company Head office and Area Served
- 3.4 Global Polymers Drug Delivery Company, Product Type & Application
- 3.5 Global Polymers Drug Delivery Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Polymers Drug Delivery Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Polymers Drug Delivery Players Market Share by Revenue in 2025
- 3.6.3 2025 Polymers Drug Delivery Tier 1, Tier 2, and Tier 3
4 Polymers Drug Delivery Market by Type
- 4.1 Global Polymers Drug Delivery Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Polymers Drug Delivery Market Size by Type (2021-2032)
- 4.3 Global Polymers Drug Delivery Market Size Share by Type (2021-2032)
5 Polymers Drug Delivery Market by Application
- 5.1 Global Polymers Drug Delivery Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Polymers Drug Delivery Market Size by Application (2021-2032)
- 5.3 Global Polymers Drug Delivery Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Eisai
- 6.1.1 Eisai Company Information
- 6.1.2 Eisai Business Overview
- 6.1.3 Eisai Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Eisai Polymers Drug Delivery Product Portfolio
- 6.1.5 Eisai Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Sanofi Polymers Drug Delivery Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Johnson & Johnson
- 6.3.1 Johnson & Johnson Company Information
- 6.3.2 Johnson & Johnson Business Overview
- 6.3.3 Johnson & Johnson Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Johnson & Johnson Polymers Drug Delivery Product Portfolio
- 6.3.5 Johnson & Johnson Recent Developments
- 6.4 Vectura Group Plc
- 6.4.1 Vectura Group Plc Company Information
- 6.4.2 Vectura Group Plc Business Overview
- 6.4.3 Vectura Group Plc Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Vectura Group Plc Polymers Drug Delivery Product Portfolio
- 6.4.5 Vectura Group Plc Recent Developments
- 6.5 Tolmar
- 6.5.1 Tolmar Company Information
- 6.5.2 Tolmar Business Overview
- 6.5.3 Tolmar Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Tolmar Polymers Drug Delivery Product Portfolio
- 6.5.5 Tolmar Recent Developments
- 6.6 SurModics
- 6.6.1 SurModics Company Information
- 6.6.2 SurModics Business Overview
- 6.6.3 SurModics Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 SurModics Polymers Drug Delivery Product Portfolio
- 6.6.5 SurModics Recent Developments
- 6.7 Quark Pharmaceuticals Inc
- 6.7.1 Quark Pharmaceuticals Inc Company Information
- 6.7.2 Quark Pharmaceuticals Inc Business Overview
- 6.7.3 Quark Pharmaceuticals Inc Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Quark Pharmaceuticals Inc Polymers Drug Delivery Product Portfolio
- 6.7.5 Quark Pharmaceuticals Inc Recent Developments
- 6.8 Perrigo
- 6.8.1 Perrigo Company Information
- 6.8.2 Perrigo Business Overview
- 6.8.3 Perrigo Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Perrigo Polymers Drug Delivery Product Portfolio
- 6.8.5 Perrigo Recent Developments
- 6.9 Nektar Therapeutics
- 6.9.1 Nektar Therapeutics Company Information
- 6.9.2 Nektar Therapeutics Business Overview
- 6.9.3 Nektar Therapeutics Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Nektar Therapeutics Polymers Drug Delivery Product Portfolio
- 6.9.5 Nektar Therapeutics Recent Developments
- 6.10 Janssen Biotech
- 6.10.1 Janssen Biotech Company Information
- 6.10.2 Janssen Biotech Business Overview
- 6.10.3 Janssen Biotech Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Janssen Biotech Polymers Drug Delivery Product Portfolio
- 6.10.5 Janssen Biotech Recent Developments
- 6.11 Inovio Pharmaceuticals
- 6.11.1 Inovio Pharmaceuticals Company Information
- 6.11.2 Inovio Pharmaceuticals Business Overview
- 6.11.3 Inovio Pharmaceuticals Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Inovio Pharmaceuticals Polymers Drug Delivery Product Portfolio
- 6.11.5 Inovio Pharmaceuticals Recent Developments
- 6.12 Heron
- 6.12.1 Heron Company Information
- 6.12.2 Heron Business Overview
- 6.12.3 Heron Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Heron Polymers Drug Delivery Product Portfolio
- 6.12.5 Heron Recent Developments
- 6.13 Gilead Sciences
- 6.13.1 Gilead Sciences Company Information
- 6.13.2 Gilead Sciences Business Overview
- 6.13.3 Gilead Sciences Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Gilead Sciences Polymers Drug Delivery Product Portfolio
- 6.13.5 Gilead Sciences Recent Developments
- 6.14 Enzon Pharmaceuticals
- 6.14.1 Enzon Pharmaceuticals Company Information
- 6.14.2 Enzon Pharmaceuticals Business Overview
- 6.14.3 Enzon Pharmaceuticals Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Enzon Pharmaceuticals Polymers Drug Delivery Product Portfolio
- 6.14.5 Enzon Pharmaceuticals Recent Developments
- 6.15 EnColl Corporation
- 6.15.1 EnColl Corporation Company Information
- 6.15.2 EnColl Corporation Business Overview
- 6.15.3 EnColl Corporation Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 EnColl Corporation Polymers Drug Delivery Product Portfolio
- 6.15.5 EnColl Corporation Recent Developments
- 6.16 Allergan
- 6.16.1 Allergan Company Information
- 6.16.2 Allergan Business Overview
- 6.16.3 Allergan Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Allergan Polymers Drug Delivery Product Portfolio
- 6.16.5 Allergan Recent Developments
- 6.17 Alkermes
- 6.17.1 Alkermes Company Information
- 6.17.2 Alkermes Business Overview
- 6.17.3 Alkermes Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Alkermes Polymers Drug Delivery Product Portfolio
- 6.17.5 Alkermes Recent Developments
7 North America
- 7.1 North America Polymers Drug Delivery Market Size (2021-2032)
- 7.2 North America Polymers Drug Delivery Market Size by Type
- 7.2.1 North America Polymers Drug Delivery Market Size by Type (2021-2026)
- 7.2.2 North America Polymers Drug Delivery Market Size by Type (2027-2032)
- 7.2.3 North America Polymers Drug Delivery Market Share by Type (2021-2032)
- 7.3 North America Polymers Drug Delivery Market Size by Application
- 7.3.1 North America Polymers Drug Delivery Market Size by Application (2021-2026)
- 7.3.2 North America Polymers Drug Delivery Market Size by Application (2027-2032)
- 7.3.3 North America Polymers Drug Delivery Market Share by Application (2021-2032)
- 7.4 North America Polymers Drug Delivery Market Size by Country
- 7.4.1 North America Polymers Drug Delivery Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Polymers Drug Delivery Market Size by Country (2021-2026)
- 7.4.3 North America Polymers Drug Delivery Market Size by Country (2027-2032)
- 7.4.4 North America Polymers Drug Delivery Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Polymers Drug Delivery Market Size (2021-2032)
- 8.2 Europe Polymers Drug Delivery Market Size by Type
- 8.2.1 Europe Polymers Drug Delivery Market Size by Type (2021-2026)
- 8.2.2 Europe Polymers Drug Delivery Market Size by Type (2027-2032)
- 8.2.3 Europe Polymers Drug Delivery Market Share by Type (2021-2032)
- 8.3 Europe Polymers Drug Delivery Market Size by Application
- 8.3.1 Europe Polymers Drug Delivery Market Size by Application (2021-2026)
- 8.3.2 Europe Polymers Drug Delivery Market Size by Application (2027-2032)
- 8.3.3 Europe Polymers Drug Delivery Market Share by Application (2021-2032)
- 8.4 Europe Polymers Drug Delivery Market Size by Country
- 8.4.1 Europe Polymers Drug Delivery Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Polymers Drug Delivery Market Size by Country (2021-2026)
- 8.4.3 Europe Polymers Drug Delivery Market Size by Country (2027-2032)
- 8.4.4 Europe Polymers Drug Delivery Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Polymers Drug Delivery Market Size (2021-2032)
- 9.2 China Polymers Drug Delivery Market Size by Type
- 9.2.1 China Polymers Drug Delivery Market Size by Type (2021-2026)
- 9.2.2 China Polymers Drug Delivery Market Size by Type (2027-2032)
- 9.2.3 China Polymers Drug Delivery Market Share by Type (2021-2032)
- 9.3 China Polymers Drug Delivery Market Size by Application
- 9.3.1 China Polymers Drug Delivery Market Size by Application (2021-2026)
- 9.3.2 China Polymers Drug Delivery Market Size by Application (2027-2032)
- 9.3.3 China Polymers Drug Delivery Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Polymers Drug Delivery Market Size (2021-2032)
- 10.2 Asia Polymers Drug Delivery Market Size by Type
- 10.2.1 Asia Polymers Drug Delivery Market Size by Type (2021-2026)
- 10.2.2 Asia Polymers Drug Delivery Market Size by Type (2027-2032)
- 10.2.3 Asia Polymers Drug Delivery Market Share by Type (2021-2032)
- 10.3 Asia Polymers Drug Delivery Market Size by Application
- 10.3.1 Asia Polymers Drug Delivery Market Size by Application (2021-2026)
- 10.3.2 Asia Polymers Drug Delivery Market Size by Application (2027-2032)
- 10.3.3 Asia Polymers Drug Delivery Market Share by Application (2021-2032)
- 10.4 Asia Polymers Drug Delivery Market Size by Country
- 10.4.1 Asia Polymers Drug Delivery Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Polymers Drug Delivery Market Size by Country (2021-2026)
- 10.4.3 Asia Polymers Drug Delivery Market Size by Country (2027-2032)
- 10.4.4 Asia Polymers Drug Delivery Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Polymers Drug Delivery Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Polymers Drug Delivery Market Size by Type
- 11.2.1 South America, Middle East & Africa Polymers Drug Delivery Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Polymers Drug Delivery Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Polymers Drug Delivery Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Polymers Drug Delivery Market Size by Application
- 11.3.1 South America, Middle East & Africa Polymers Drug Delivery Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Polymers Drug Delivery Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Polymers Drug Delivery Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Polymers Drug Delivery Market Size by Country
- 11.4.1 South America, Middle East & Africa Polymers Drug Delivery Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Polymers Drug Delivery Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Polymers Drug Delivery Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Polymers Drug Delivery Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst